Real Time Phylogeny and Contact Tracing to Disrupt HIV Transmission
Real Time Phylogeny and Contact Tracing to Disrupt HIV Transmission
批准号:
10097973
负责人:
Rami Kantor
金额:
$66.16万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-03-05 至 2023-02-28
关键词:
AIDS preventionAddressAwarenessCaringCharacteristicsCollaborationsContact TracingContinuity of Patient CareDataDeveloped CountriesDevelopmentDiagnosisDisease OutbreaksDrug resistanceDrug usageEpidemicEpidemiologyEthicsFailureGoalsGrowthGuide preventionGuidelinesHIVHIV InfectionsHIV diagnosisHIV drug resistanceHealthHuman immunodeficiency virus testImpact evaluationIndividualInfectionInstitutionIntravenousInvestigationLeadLinkMethodologyMethodsModalityMolecularMolecular EpidemiologyNewly DiagnosedOutcomePatientsPatternPersonsPhylogenetic AnalysisPhylogenyPopulationPrevention strategyPublic HealthPublic Health Applications ResearchResearchResource AllocationResourcesRhode IslandRiskRisk BehaviorsSamplingSocial ImpactsSocial NetworkTestingTimeVisionclinical caredisorder controlexperiencefollow-uphigh riskhigh risk behaviorimprovedindexinginfection riskinnovationintravenous drug usermen who have sex with menmultidisciplinarynovelpreventpreventive interventionprospectivesocialstandard of caretime usetooltransmission process
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Real Time Phylogeny and Contact Tracing to Disrupt HIV Transmission Kantor, Rami MD
SUMMARY
Prevention of HIV transmission is still a major global challenge, and innovative methods are needed for its
disruption. Though actual transmission networks are unknown, characterizing social and phylogenetic
networks can guide prevention interventions. Contact tracing is the current public health tool to derive social
networks and identify, notify, test and link to care partners of newly-diagnosed HIV cases. Phylogenetic
analysis of available sequences is used in research to characterize epidemics and has facilitated outbreak
investigations. However, real time integration of phylogenetics with contact tracing on a public health, state-
wide level has not been evaluated. We propose to prospectively integrate phylogenetic analysis with contact
tracing in real time, and evaluate the impact of such integration on HIV infection in Rhode Island (RI). We
hypothesize that real time use of information from phylogenetic inference can enhance contact tracing,
improve HIV testing, diagnoses and linkage to care, and disrupt transmission. The Specific Aims are to: (1)
Conduct real time phylogenetic analyses of patient-level sequence data; (2) Augment phylogenetic inference
by increased sampling and more comprehensive testing; and (3) Evaluate the benefit of real time integration of
phylogenetics with contact tracing efforts. We will develop and automate tools to incorporate phylogenetic and
phylodynamic inference into contact tracing, explore its enhancement, and evaluate its real time impact, with
special consideration of key populations like men who have sex with men, intravenous drug users and persons
with HIV drug resistance. We expect that this approach will improve identification and linkage to care of
infected-unaware individuals, infected-aware individuals not linked to care, and uninfected individuals that are
at high risk of infection. The main premise of this proposal is that phylogenetic networks contain
information which can expand social networks and impact HIV transmission. If our hypothesis is correct,
this research will have high impact on HIV prevention and the care continuum and disrupt HIV transmission in
Rhode Island. The rigor of our research approach is strengthened by our multidisciplinary team of clinicians,
public health officials, statisticians, bioinformaticians, evolutionary and molecular biologists, combined with our
relevant existing data and expertise, the small size of the state and the strong and close academic-public
health partnership. Furthermore, important and essential ethics considerations are directly addressed and
incorporated throughout. Such an approach will make results generalizable and sustainable, allowing focused
resource allocation and continuous implementation and generalization of findings. In 2013 the Director of the
RI Department of Health declared the vision of ‘Getting to Zero’ new HIV infections in the state within the next
five years, however apparent increases in transmission among high risk networks has impeded progress. This
proposal will help bring small RI closer to its goal of being the first state to get to zero new infections and
demonstrate how focusing efforts can prevent HIV transmission in RI and beyond.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Addressing HIV drug resistance research gaps in a cohort of perinatally infected Kenyan children and adolescents
-
批准号:10630333
-
项目类别:
-
资助金额:$69.3万
-
财政年份:2019
-
负责人:Rami Kantor
-
依托单位:
HIV Treatment Failure and Drug Resistance in Western Kenyan Children
-
批准号:9925893
-
项目类别:
-
资助金额:$72.0万
-
财政年份:2019
-
负责人:Rami Kantor
-
依托单位:
Real Time Phylogeny and Contact Tracing to Disrupt HIV Transmission
-
批准号:10335147
-
项目类别:
-
资助金额:$64.77万
-
财政年份:2018
-
负责人:Rami Kantor
-
依托单位:
HIV Treatment Failure and Drug Resistance in Western Kenyan Children
-
批准号:9147181
-
项目类别:
-
资助金额:$75.23万
-
财政年份:2016
-
负责人:Rami Kantor
-
依托单位:
HIV Treatment Failure and Drug Resistance in Western Kenyan Children
-
批准号:9324832
-
项目类别:
-
资助金额:$70.21万
-
财政年份:2016
-
负责人:Rami Kantor
-
依托单位:
HIV Drug Resistance Monitoring in Chennai, India
-
批准号:8540028
-
项目类别:
-
资助金额:$20.69万
-
财政年份:2013
-
负责人:Rami Kantor
-
依托单位:
HIV Drug Resistance Monitoring in Chennai, India
-
批准号:8709987
-
项目类别:
-
资助金额:$21.04万
-
财政年份:2013
-
负责人:Rami Kantor
-
依托单位:
Antiretroviral Treatment Failure and Drug Resistance in HIV-infected Patients on
-
批准号:8150159
-
项目类别:
-
资助金额:$35.88万
-
财政年份:2010
-
负责人:Rami Kantor
-
依托单位:
HIV-1 Drug Resistance in Different Subtypes
-
批准号:8139079
-
项目类别:
-
资助金额:$81.14万
-
财政年份:2008
-
负责人:Rami Kantor
-
依托单位:
HIV-1 Drug Resistance in Different Subtypes
-
批准号:8265504
-
项目类别:
-
资助金额:$11.9万
-
财政年份:2008
-
负责人:Rami Kantor
-
依托单位:
HIV-1 Drug Resistance in Different Subtypes
-
批准号:7555206
-
项目类别:
-
资助金额:$73.71万
-
财政年份:2008
-
负责人:Rami Kantor
-
依托单位:
HIV-1 Drug Resistance in Different Subtypes
-
批准号:8320223
-
项目类别:
-
资助金额:$62.28万
-
财政年份:2008
-
负责人:Rami Kantor
-
依托单位:
HIV-1 Drug Resistance in Different Subtypes
-
批准号:7676787
-
项目类别:
-
资助金额:$62.64万
-
财政年份:2008
-
负责人:Rami Kantor
-
依托单位:
HIV-1 Drug Resistance in Different Subtypes
-
批准号:7906662
-
项目类别:
-
资助金额:$63.93万
-
财政年份:2008
-
负责人:Rami Kantor
-
依托单位:
Core H - Basic Science Core
-
批准号:10672714
-
项目类别:
-
资助金额:$26.33万
-
财政年份:1998
-
负责人:Rami Kantor
-
依托单位:
海外基金